[14C] mechlorethamine binding to proteins of the human keratinocyteDEATON, M. A; JONES, G. P; BOWMAN, P. D et al.Military medicine. 1990, Vol 155, Num 10, pp 477-480, issn 0026-4075Article

Modifications and insights into a method for the analysis of the nitrogen mustard mechlorethamine by high-performance liquid chromatographyREEPMEYER, John C; WEI YE; RITSCHEL, Wolfgang A et al.Analytica chimica acta. 2008, Vol 616, Num 1, pp 78-84, issn 0003-2670, 7 p.Article

Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's diseaseHARDING, M. J; MCNULTY, L. J; PAUL, J et al.European journal of cancer : (1990). 1991, Vol 27, Num 8, pp 1002-1006Article

Effect of nitrogen mustard, a vesicant agent, on lymphocyte energy metabolismKENAR, Levent; BOYUNAGA, Hakan; SERDAR, Muhittin et al.Clinical chemistry and laboratory medicine. 2006, Vol 44, Num 10, pp 1253-1257, issn 1434-6621, 5 p.Article

Topical mechlorethamine in the treatment of mycosis fungoides : uniformity of application and potential for environmental contaminationBRENEMAN, D. L; NARTKER, A. L; BALLMAN, E. A et al.Journal of the American Academy of Dermatology. 1991, Vol 25, Num 6, pp 1059-1064, issn 0190-9622, 1Article

Excision of DNA adducts of nitrogen mustards by bacterial and mammalian 3-methyladenine-DNA glycosylasesMATTES, W. B; LEE, C.-S; LAVAL, J et al.Carcinogenesis (New York. Print). 1996, Vol 17, Num 4, pp 643-648, issn 0143-3334Article

Effect of ionic strength and cationic DNA affinity binders on the DNA sequence selective alkylation of guanine N7-positions by nitrogen mustardsHARTLEY, J. A; FORROW, S. M; SOUHAMI, R. L et al.Biochemistry (Easton). 1990, Vol 29, Num 12, pp 2985-2991, issn 0006-2960, 7 p.Article

A clinically relevant in vitro model for evaluating the effects of aerosolized vesicantsKARACSONYI, Claudia; SHANMUGAM, Naga; KAGAN, Elliott et al.Toxicology letters. 2009, Vol 185, Num 1, pp 38-44, issn 0378-4274, 7 p.Article

Mycosis Fungoides in a Lung Transplant Recipient with Advanced Ciclosporin Nephropathy : Management with Mechlorethamine and Subsequent Renal TransplantationLAFFITTE, Emmanuel; VENETZ, Jean-Pierre; AUBERT, John-David et al.Dermatology (Basel). 2008, Vol 217, Num 1, pp 87-88, issn 1018-8665, 2 p.Article

REDUCTION OF VESICANT TOXICITY BY BUTYLATED HYDROXYANISOLE IN A-431 SKIN CELLSPINO, Maria A; BILLACK, Blase.Cutaneous and ocular toxicology (Print). 2008, Vol 27, Num 3, pp 161-172, issn 1556-9527, 12 p.Article

Hepatocyte toxicity of mechlorethamine and other alkylating anticancer drugs : role of lipid peroxidationKHAN, S; RAMWANI, J. J; O'BRIEN, P. J et al.Biochemical pharmacology. 1992, Vol 43, Num 9, pp 1963-1967, issn 0006-2952Article

The in vivo and in vitro effects of an alkylating agent, mechlorethamine, on IL-6 production in mice and the role of macrophagesBRYNIARSKI, K; PTAK, M; PTAK, W et al.Immunopharmacology (New York). 1996, Vol 34, Num 2-3, pp 73-78, issn 0162-3109Article

The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphomaVONDERHEID, E. C; EKBOTE, S. K; KERRIGAN, K et al.Journal of investigative dermatology. 1998, Vol 110, Num 6, pp 946-950, issn 0022-202XArticle

Nitrobenzyl mustard quaternary salts : a new class of hypoxia-selective cytotoxins showing very high in vitro selectivityTERCEL, M; WILSON, W. R; DENNY, W. A et al.Journal of medicinal chemistry (Print). 1993, Vol 36, Num 17, pp 2578-2579, issn 0022-2623Article

The lack of effects of alkylating agents on mammalian cell membranesANKEL, E. G; RING, B. J; LAI, C.-S et al.International journal of tissue reactions. 1986, Vol 8, Num 5, pp 347-354, issn 0250-0868Article

Stress protein synthesis in human keratinocytes treated with sodium arsenite, phenyldichloroarsine, and nitrogen mustardDEATON, M. A; BOWMAN, P. D; JONES, G. P et al.Fundamental and applied toxicology (Print). 1990, Vol 14, Num 3, pp 471-476, issn 0272-0590Article

Chlorpromazine-induced hypothermia in tumour-bearing mice, acute cytotoxic drug lethality and long-term survivalHULTBORN, R; LUNDGREN-ERIKSSON, L; OTTOSSON-LÖNN, S et al.Acta oncologica (Stockholm). 1990, Vol 29, Num 7, pp 941-944, issn 0284-186XArticle

IL CORDOMA. DESCRIZIONE DI DUE CASI CLINICI E RISULTATI DELLA CHEMIOTERAPIA ONCOLITICA = LE CHORDOME. DESCRIPTION DE 2 CAS CLINIQUES ET RESULTATS DE LA CHIMIOTHERAPIE ONCOLYTIQUEMENSI F; BOMBARA R; MASSARI A et al.1979; MINERVA MED.; ITA; DA. 1979; VOL. 70; NO 40; PP. 2759-2766; BIBL. 28 REF.Article

Topical nitrogen mustard : an effective treatment for cutaneous langerhans cell histiocytolisSHEEHAN, M. P; ATHERTON, D. J; BROADBENT, V et al.The Journal of pediatrics. 1991, Vol 119, Num 2, pp 317-321, issn 0022-3476Article

Topical nitrogen mustard ointment with occlusion for Langerhans' cell histiocytosis of the scalpTREAT, J. R; SUCHIN, K. R; JAMES, W. D et al.Journal of dermatological treatment. 2003, Vol 14, Num 1, pp 46-47, issn 0954-6634, 2 p.Article

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease : a preliminary reportBARTLETT, N. L; ROSENBERG, S. A; HOPPE, R. T et al.Journal of clinical oncology. 1995, Vol 13, Num 5, pp 1080-1088, issn 0732-183XArticle

Expression of ribosomal phosphoprotein PO is induced by antitumor agents and increased in Mer^- human tumor cell linesGRABOWSKI, D. T; PIEPER, R. O; FUTSCHER, B. W et al.Carcinogenesis (New York. Print). 1992, Vol 13, Num 2, pp 259-263, issn 0143-3334Article

The in vivo genetic activity profile of the monofunctional nitrogen mustard 2-chloroethylamine differs drastically from its bifunctional counterpart mechlorethamineWIJEN, John P. H; NIVARD, Madeleine J. M; VOGEL, Ekkehart W et al.Carcinogenesis (New York. Print). 2000, Vol 21, Num 10, pp 1859-1867, issn 0143-3334Article